Next Article in Journal
Simultaneous LC-ESI-MS/MS Quantification of Levosimendan and Its Metabolites for Therapeutic Drug Monitoring of Cardiac Surgery Patients
Next Article in Special Issue
Novel Anticancer Strategies II
Previous Article in Journal
Brain Delivery of IGF1R5, a Single-Domain Antibody Targeting Insulin-like Growth Factor-1 Receptor
Previous Article in Special Issue
PD-1 Cellular Nanovesicles Carrying Gemcitabine to Inhibit the Proliferation of Triple Negative Breast Cancer Cell
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(7), 1453; https://doi.org/10.3390/pharmaceutics14071453
Action Date Notes Link
article xml file uploaded 12 July 2022 12:30 CEST Original file -
article xml uploaded. 12 July 2022 12:30 CEST Update https://www.mdpi.com/1999-4923/14/7/1453/xml
article pdf uploaded. 12 July 2022 12:30 CEST Version of Record https://www.mdpi.com/1999-4923/14/7/1453/pdf
article html file updated 12 July 2022 12:31 CEST Original file -
article html file updated 12 July 2022 12:32 CEST Update -
article html file updated 12 July 2022 12:32 CEST Update -
article html file updated 13 August 2022 01:21 CEST Update https://www.mdpi.com/1999-4923/14/7/1453/html
Back to TopTop